← Leaderboards
Stephanie Gaillard
Johns Hopkins University
$1,082,922
Attributed
$1,082,922
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $555.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,082,922 · 2
By mechanism
P50$749,821 · 1
R50$333,101 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ie-Ming Shih$14,895,140
- Eneda Toska$2,070,381
- Victor E Velculescu$5,783,536
- Roberto Pili$5,318,216
- Xinzhong Dong$16,603,888
Others in their field
Other Rising Stars on “Molecular”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
MolecularPhysiciansEducationMinority GroupsParticipant EnrollmentPersonalized MedicineComprehensive Cancer CenterDecision MakingEquityLeadNational Clinical Trials NetworkCaringBiological MarkersPatient-Focused OutcomesClinical TrialsClinical Trials NetworkCancer CareComputerized Medical RecordEligibility DeterminationEnsureCancer CenterInvestigational TherapiesClinical Trial EnrollmentPlay
Grant awards (5)
Project 3: Investigating new treatment approaches based on DNA repair vulnerability in ARID1A mutated type I ovarian cancer$300,357
P50 · FY2025 · CA · contact PI
Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist$105,619
R50 · FY2025 · CA · contact PI
Project 3: Investigating new treatment approaches based on DNA repair vulnerability in ARID1A mutated type I ovarian cancer$449,464
P50 · FY2024 · CA · contact PI
Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist$105,619
R50 · FY2024 · CA · contact PI
Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist$121,863
R50 · FY2023 · CA · contact PI